Product image of Niflugel (Niflumic Acid) supplied by GNH India

Niflugel

Active Ingredient:
Niflumic Acid
Origin:
EU

Niflugel (Niflumic Acid)

Niflumic Acid, the active ingredient in Niflugel, is a NSAID (fenamate) presented as a topical gel for skin application. It is used to alleviate localized inflammation and pain in musculoskeletal conditions and is applied directly to the affected area.\n\nGNH India supplies Niflugel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Upsa Sas

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Niflugel is a topical NSAID that targets inflammatory processes in the musculoskeletal system.\n\n- Musculoskeletal pain: provides localized relief of pain associated with sprains, strains and overuse injuries.\n- Tendonitis: reduces inflammation and discomfort in inflamed tendons.\n- Bursitis: alleviates swelling and pain in inflamed bursae.\n- Osteoarthritis flare‑ups: helps manage joint pain and stiffness in affected areas.

How It Works

  • Niflumic Acid exerts its anti‑inflammatory effect by non‑selectively inhibiting cyclooxygenase (COX‑1 and COX‑2) enzymes, which decreases the synthesis of prostaglandins that mediate pain, swelling and fever. The reduced prostaglandin production limits the inflammatory cascade at the site of application, providing localized analgesic and anti‑edematous activity.

Side Effects

  • Topical Niflugel may cause skin‑related reactions and, rarely, systemic adverse events.\n\nCommon Side Effects:\n- Local skin irritation: burning or stinging sensation at the application site.\n- Redness: mild erythema where the gel is applied.\n- Itching: pruritus localized to the treated area.\n- Dryness: skin may become dry or flaky.\n- Contact dermatitis: mild allergic skin reaction.\n\nSerious or Rare Side Effects:\n- Severe allergic reaction: swelling, hives, or difficulty breathing.\n- Stevens‑Johnson syndrome or toxic epidermal necrolysis.\n- Systemic NSAID effects: gastrointestinal ulceration or bleeding if absorbed in significant amounts.\n- Renal impairment: reduced kidney function in susceptible individuals.

Precautions & Warnings

  • When using Niflugel, consider the following safety measures.\n\n- Assess skin integrity: ensure the skin is intact before application.\n- Avoid broken skin: do not apply to cuts, abrasions or open wounds.\n- Keep away from eyes and mucous membranes: avoid contact with eyes, mouth and genitals.\n- Limit duration: use only for the prescribed period, typically not exceeding 7‑10 days without medical review.\n- Concomitant systemic NSAIDs: avoid using other NSAIDs simultaneously to reduce risk of systemic toxicity.\n- Store at room temperature: keep in the original container, protect from moisture and direct heat.

Avoid Interactions

  • Topical Niflugel can interact with other medicines, especially those affecting coagulation or systemic NSAID exposure.\n\nMajor Interactions (Avoid):\n- Systemic NSAIDs: combined use may increase risk of gastrointestinal bleeding.\n- Anticoagulants (e.g., warfarin): may enhance anticoagulant effect and bleeding risk.\n- Lithium: topical NSAIDs can raise serum lithium levels.\n\nModerate Interactions (Monitor Closely):\n- Corticosteroids: concurrent use may increase skin thinning.\n- Methotrexate: monitor for additive toxicity.\n- ACE inhibitors or diuretics: watch for renal function changes in susceptible patients.

Frequently Asked Questions

Niflugel is a topical gel containing Niflumic Acid, a fenamate NSAID. It is applied to the skin to relieve localized inflammation and pain associated with musculoskeletal conditions such as sprains, tendonitis, bursitis and osteoarthritis flare‑ups.

Niflumic Acid inhibits both COX‑1 and COX‑2 enzymes, reducing the production of prostaglandins that drive inflammation, pain and swelling. By lowering prostaglandin levels at the site of application, the gel provides localized anti‑inflammatory and analgesic effects.

The appropriate amount of Niflugel to apply and the frequency of use are determined by the prescribing healthcare professional based on the specific condition, severity and patient factors. Patients should follow the prescriber’s instructions and the product label.

Safety of topical Niflumic Acid in pregnancy or lactation has not been fully established. Healthcare providers should evaluate the potential benefits and risks before prescribing Niflugel to pregnant or nursing individuals.

To request Niflugel, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Niflugel contains Niflumic Acid, a fenamate class NSAID, which offers a broad COX inhibition profile. Compared with other topical NSAIDs such as diclofenac or ibuprofen gels, Niflugel may provide comparable analgesic efficacy but differs in chemical structure and specific tolerability profile. Choice of product depends on clinical response and individual patient factors.

Store Niflugel at room temperature, below 25 °C. Keep the gel in its original packaging, protect it from moisture, direct sunlight and excessive heat to maintain stability and potency.

Niflugel is applied topically to the affected skin area. A thin layer is spread gently and massaged until absorbed, usually 2‑4 times daily, or as directed by the prescriber. Hands should be washed before and after application.

Serious risks include severe allergic reactions such as Stevens‑Johnson syndrome, systemic NSAID‑related effects like gastrointestinal bleeding or renal impairment, and rare cases of significant skin necrosis. Patients should seek immediate medical attention if they experience widespread rash, swelling, or signs of systemic toxicity.

Niflugel should be avoided in individuals with known hypersensitivity to Niflumic Acid or any component of the gel, those with broken or infected skin at the intended site, and patients taking systemic anticoagulants or other NSAIDs without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Niflumic Acid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT